These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 24674147)
1. The molecular biology of renal cancer: another piece of the puzzle. Stewart GD; Harrison DJ; Berney DM; Powles T Eur Urol; 2014 Jul; 66(1):85-6. PubMed ID: 24674147 [No Abstract] [Full Text] [Related]
3. Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. Parker AS; Leibovich BC; Eckel-Passow JE; Cheville JC Eur Urol; 2014 Nov; 66(5):e90-1. PubMed ID: 24877662 [No Abstract] [Full Text] [Related]
4. Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. Rathmell WK; Brooks SA; Parker JS; Nielsen ME Eur Urol; 2014 Nov; 66(5):e92. PubMed ID: 25037640 [No Abstract] [Full Text] [Related]
5. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)]. Herrmann E; Wülfing C; Hartmann A Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959 [No Abstract] [Full Text] [Related]
6. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Liu Y; Liu H; Liu W; Zhang W; An H; Xu J World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622 [TBL] [Abstract][Full Text] [Related]
7. Kidney cancer: When worlds collide--integrating metabolic and transcriptomic data in ccRCC. Thoma C Nat Rev Urol; 2016 Mar; 13(3):126. PubMed ID: 26813954 [No Abstract] [Full Text] [Related]
8. Type 1 and 2 papillary renal cancers are genetically distinct. Balakrishnan VS Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671 [No Abstract] [Full Text] [Related]
14. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243 [TBL] [Abstract][Full Text] [Related]
15. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data. Guan L; Tan J; Li H; Jin X Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611 [TBL] [Abstract][Full Text] [Related]
16. Kidney cancer: DA transporter a ccRCC biomarker? Fenner A Nat Rev Urol; 2016 Nov; 13(11):629. PubMed ID: 27725638 [No Abstract] [Full Text] [Related]
17. Facial fibrofolliculomas as indicator for renal cell cancer. Johannesma PC; Starink TM; Van Moorselaar RJ; Postmus PE Jpn J Clin Oncol; 2014 Jun; 44(6):609-10. PubMed ID: 24864271 [No Abstract] [Full Text] [Related]
18. Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma. Ambrosio MR; Rocca BJ; Barone A; Onorati M; Mundo L; Crivelli F; Di Nuovo F; De Falco G; del Vecchio MT; Tripodi SA; Tosi P Biomed Res Int; 2015; 2015():730390. PubMed ID: 26425551 [TBL] [Abstract][Full Text] [Related]
19. Re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91. Verine J; Leboeuf C; Ratajczak P Eur Urol; 2014 May; 65(5):e69-70. PubMed ID: 24341959 [No Abstract] [Full Text] [Related]
20. Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Komai Y; Fujii Y; Iimura Y; Tatokoro M; Saito K; Otsuka Y; Koga F; Arisawa C; Kawakami S; Okuno T; Tsujii T; Kageyama Y; Morimoto S; Toma T; Higashi Y; Fukui I; Kihara K Urology; 2011 Apr; 77(4):842-7. PubMed ID: 21256565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]